The National Academies Press

Currently Skimming:

Appendix E: Agendas and Participants in Committee Workshops
Pages 474-489

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.

From page 474... ... MENSES INDUCERS Paul Van Look, overview Horacio Croxatto 11:00 a.m. BARRIERS AGAINST STD/HIV AND HIV ATTACHMENT-PREVENTION Nancy Alexander, overview Lourens Zaneveld 474 Read the entire page →
From page 475... ... AREA 1 -- BASIC GENETICS Genetic screening and mapping, gene expression, and transcription factors Moderator: Bert O'Malley Principals: Walter Gilbert Donald McDonnell David Page Allen Spradling 3:30 p.m. AREA 2 -- CONTROL/ACTION Signal transduction, releasing factors, RAFT proteins, ion channels, peptide receptors, and steroid hormone synthesis Moderator: Jerome Strauss Principals: Bertil Hille Andrés Negro-Vilar Neena Schwartz Roy Smith Robert Stein 5:00 p.m. Read the entire page →
From page 476... ... AREA 4 -- POST-FERTILIZATION TO IMPLANTATION Angiogenesis, apoptosis, and implantation (cytokine function, integrin biology, and trophoblast invasion) Moderator: Susan Fisher Principals: Mina Bissell Michael Harper Judah Folkman Bruce Lessey 12:00 p.m. Read the entire page →
From page 477... ... Cook National Institute for Child Health Associate Professor and Human Development Faculty of Law National Institutes of Health University of Toronto Read the entire page →
From page 478... ... Program Professor, Department of Obstetrics Richard H Douglas and Gynecology Vice President for Corporate Eastern Virginia Medical School Development Genzyme Corporation David L Read the entire page →
From page 479... ... Negro-Vilar Division of Health Sciences Policy Director Institute of Medicine Women's Health Research Institute, and William J Lennarz Vice President Department of Biochemistry and Cell Wyeth-Ayerst Research Biology State University of New York Read the entire page →
From page 480... ... Shapiro Vector Fund Management Executive Vice President Worldwide Basic Research Gordon W Perkin Merck Research Laboratories President Program for Appropriate Technology Valerie Setlow in Health (PATH) Read the entire page →
From page 481... ... Debra J Wolgemuth Robert Stein Professor of Human Genetics and Senior Vice President, and Development Chief Scientific Officer College of Physicians and Surgeons Ligand Pharmaceuticals Columbia University Jerome F Read the entire page →
From page 482... ... SESSION 1: WHAT WE HAVE DONE SO FAR 9:15 a.m. Thoughts and Conclusions from Bellagio Conference, April 10–14, 1995, on Public- and Private-Sector Collaboration in Contraceptive Research and Development Mahmoud Fathalla 10:00 a.m. Read the entire page →
From page 483... ... Lunch 1:30 p.m. The Legal and Regulatory Scene: Changes and Perspectives at the FDA Philip Corfman Tort Reform Update Ellen Flannery 2:30 p.m. Read the entire page →
From page 484... ... Working Group Presentations by Rapporteurs Response Panel and Discussion Conclusions, Recommendations, Followup [A panel of individuals with expertise in the areas addressed on Day 1 will react to the conclusions and recommendations reported by each group, and moderate comments from the workshop audience as a whole.] Read the entire page →
From page 485... ... Bond HealthCare Investment Corporation President The Burroughs Wellcome Fund Scott Chappel Senior Scientific Advisor Lance Bronnenkant Ares-Serono President and Chief Executive Officer Finishing Enterprises, USA Michael Cohen Scientific Director Donald D Brown* Read the entire page →
From page 486... ... Garbers Reproductive Health Research Patrick E Haggerty Distinguished The Rockefeller Foundation, and Chair in Basic Biomedical Science Professor of Obstetrics and Howard Hughes Medical Institute Gynaecology University of Texas Southwestern Assiut University Medical Center at Dallas Diane Feldman Philip Gevas Vice President for Over-the-Counter President and Chief Executive Officer Business Aphton Pharmaceuticals Syntex Corporation Michael J.K. Read the entire page →
From page 487... ... , US Division of Health Sciences Policy Public Health Service, and Institute of Medicine Executive Director, Federal Medical Affairs Robert Howells The Upjohn Company Director, Population Initiative The Wellcome Trust Ernest Loumaye Corporate Ob/Gyn Director Leonard Jacob Medical Affairs Department Executive Vice President and Chief Serono Corporation Operating Officer Magainin Pharmaceuticals Carolyn Makinson* Read the entire page →
From page 488... ... Worldwide Basic Research President Merck Research Laboratories Vector Fund Management William C Sheldon Audrey Phillips President and Chief Executive Officer Research Manager Applied Medical Research, Ltd. Read the entire page →
From page 489... ... D Zaneveld National Institute of Child Health and Research Director Human Development Women's Health Research Center National Institutes of Health Professor, Department of Obstetrics and Gynecology, and Department Laura Tangley of Biochemistry Science Writer for the Institute of Rush University, Rush-St. Read the entire page →

From page 474...

... MENSES INDUCERS Paul Van Look, overview Horacio Croxatto 11:00 a.m. BARRIERS AGAINST STD/HIV AND HIV ATTACHMENT-PREVENTION Nancy Alexander, overview Lourens Zaneveld 474

Appendix E: Agendas and Participants in Committee Workshops Pages 474-489

Appendix E: Agendas and Participants in Committee Workshops
Pages 474-489